MAXIMUS Secures $325M Term Loan, Partially Funding Share Repurchase Program
MMS is trading near its 52-week low of $56.92 (10% above the low).
Summary
Maximus secured a $325 million term loan, with proceeds allocated to repay revolving loans, fund working capital, and partially finance its recently authorized share repurchase program.
Key Events · Financing and Capital Events · MMS
-
New $325 Million Term Loan
Maximus entered into a Second Amendment to its Credit Agreement, establishing $325 million in new Tranche B-1 Term Loans.
-
Funding for Share Repurchase
A portion of the loan proceeds will be used to repurchase the company's capital stock, supporting the $400 million share repurchase program authorized on May 7, 2026.
-
Debt Structure Update
The new Tranche B-1 Term Loans will be fungible with existing Tranche B Term Loans, forming a single tranche. Quarterly amortization payments for this combined tranche will commence in June 2026.
Analysis · MMS · Trade & Services
MAXIMUS, INC. has entered into a Second Amendment to its Credit Agreement, securing $325 million in new Tranche B-1 Term Loans. A significant portion of these proceeds will be used to repurchase the company's capital stock, directly supporting the previously announced $400 million share repurchase program from May 7, 2026. This financing enables a shareholder-friendly action following strong fiscal Q2 results and raised full-year guidance.
At the time of this filing, MMS was trading at $62.88 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $56.92 to $100.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.